Philippe L, Mena I, Darcourt J, French W J
Division of Nuclear Medicine, Harbor-UCLA Medical Center, Torrance 90509.
J Nucl Med. 1988 Feb;29(2):159-67.
We have evaluated left ventricular regurgitation by means of factor analysis of 99mTc first-pass radionuclide angiography (FPRNA) and time-activity curve deconvolution. The FPRNA regurgitant fraction (RF) was computed in 26 individuals: 13 patients (eight mitral, three aortic, and two mitral-aortic) and 13 controls. The reference method was contrast ventriculography (CV) performed within 1 hr after FPRNA. In 19 patients, CV was preceded by the determination of cardiac output, using indocyanine green dye (n = 16) or thermodilution technique (n = 3), to determine a catheterization regurgitant fraction (CATH-RF). Lung and left ventricular (LV) time-activity curves were gathered by factor analysis and the FPRNA regurgitant fraction assessed by a lagged normal deconvolution of these curves. In valvular regurgitation, the LV deconvolved curve demonstrates the appearance of a long transit time component that is amenable to quantification. The presence of regurgitation was determined by contrast ventriculography. With a 10% RF as an acceptable upper limit of normal for nonregurgitant patients, FPRNA yielded one false-negative and no false-positive studies (n = 26), while CATH-RF yielded two false-negative and four false-positive determinations (n = 19). The following are results of quantitative determination of RF (mean +/- s.d.): FPRNA 0.39 +/- 0.19 (n = 13 Valvular), 0.01 +/- 0.03 (n = 13 Controls); CATH 0.34 +/- 0.24 (n = 11 Valvular), 0.13 +/- 0.12 (n = eight controls). FPRNA was able to differentiate (p less than 0.001) between control patients (CV grading 0) and mild/moderate regurgitation (CV grading 1+ or 2+) and severe regurgitation (3+ or 4+) (p less than 0.025).
我们通过对99mTc首次通过放射性核素血管造影(FPRNA)和时间-活性曲线反卷积进行因子分析,对左心室反流进行了评估。在26名个体中计算了FPRNA反流分数(RF):13名患者(8名二尖瓣反流、3名主动脉瓣反流和2名二尖瓣-主动脉瓣反流)和13名对照者。参考方法是在FPRNA后1小时内进行的对比心室造影(CV)。在19名患者中,在CV之前使用吲哚菁绿染料(n = 16)或热稀释技术(n = 3)测定心输出量,以确定导管反流分数(CATH-RF)。通过因子分析收集肺和左心室(LV)时间-活性曲线,并通过对这些曲线进行滞后正态反卷积来评估FPRNA反流分数。在瓣膜反流中,LV反卷积曲线显示出一个可量化的长传输时间成分的出现。反流的存在通过对比心室造影确定。以10%的RF作为非反流患者正常的可接受上限,FPRNA产生1例假阴性且无假阳性研究(n = 26),而CATH-RF产生2例假阴性和4例假阳性测定(n = 19)。以下是RF定量测定的结果(平均值±标准差):FPRNA 0.39±0.19(n = 13名瓣膜反流患者),0.01±0.03(n = 13名对照者);CATH 0.34±0.24(n = 11名瓣膜反流患者),0.13±0.12(n = 8名对照者)。FPRNA能够区分(p < 0.001)对照患者(CV分级0)与轻度/中度反流(CV分级1+或2+)和重度反流(3+或4+)(p < 0.025)。